Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-25-004648
Filing Date
2025-01-21
Accepted
2025-01-21 06:06:35
Documents
80

Document Format Files

Seq Description Document Type Size
1 FORM S-1 rsls-20231231xs1.htm   iXBRL S-1 4627619
2 EXHIBIT 23.2 rsls-20231231xex23d2.htm EX-23.2 2154
3 EXHIBIT 23.3 rsls-20231231xex23d3.htm EX-23.3 2894
4 EX-FILING FEES rsls-20231231xexfees.htm EX-FILING FEES 19737
10 GRAPHIC rsls-20231231xs1007.jpg GRAPHIC 12554
11 GRAPHIC rsls-20231231xs1010.jpg GRAPHIC 68820
  Complete submission text file 0001104659-25-004648.txt   12365476

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE rsls-20231231.xsd EX-101.SCH 60634
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rsls-20231231_cal.xml EX-101.CAL 76509
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rsls-20231231_def.xml EX-101.DEF 299306
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20231231_lab.xml EX-101.LAB 538520
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20231231_pre.xml EX-101.PRE 450038
83 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20231231xs1_htm.xml XML 1698630
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284362 | Film No.: 25540286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)